Clinical Trial Update: Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This document provides an update on a Phase 1 trial evaluating BNT317 for advanced solid tumors. It discusses safety and early signals of effectiveness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• BNT317

Snippet

Sponsor: BioNTech SE | Conditions: Advanced Solid Tumor | Phase 1 | Status: RECRUITING